Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Posttraumatic Stress Disorder and Cancer Risk: A Nested Case-Control Study.

Cohn E, Lurie I, Yang YX, Bilker WB, Haynes K, Mamtani R, Shacham-Shmueli E, Margalit O, Boursi B.

J Trauma Stress. 2018 Dec 6. doi: 10.1002/jts.22345. [Epub ahead of print]

PMID:
30520529
2.

Total Serum Cholesterol and Pancreatic Cancer: A Nested Case-Control Study.

Chen WC, Boursi B, Mamtani R, Yang YX.

Cancer Epidemiol Biomarkers Prev. 2018 Oct 17. pii: cebp.0421.2018. doi: 10.1158/1055-9965.EPI-18-0421. [Epub ahead of print]

PMID:
30333217
3.

Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case-Control Study.

Eshet Y, Baruch EN, Shapira-Frommer R, Steinberg-Silman Y, Kuznetsov T, Ben-Betzalel G, Daher S, Gluck I, Asher N, Apter S, Schachter J, Bar J, Boursi B, Markel G.

Cancer Immunol Res. 2018 Dec;6(12):1453-1458. doi: 10.1158/2326-6066.CIR-17-0659. Epub 2018 Oct 1.

PMID:
30275274
4.

Possible immune adverse events as predictors of durable response to BRAF inhibitors in patients with BRAF V600-mutant metastatic melanoma.

Ben-Betzalel G, Baruch EN, Boursi B, Steinberg-Silman Y, Asher N, Shapira-Frommer R, Schachter J, Markel G.

Eur J Cancer. 2018 Sep;101:229-235. doi: 10.1016/j.ejca.2018.06.030. Epub 2018 Aug 7.

PMID:
30096703
5.

A new look at the International Duration Evaluation of Adjuvant therapy (IDEA) classification-Defining novel predictive and prognostic markers in stage III colon cancer.

Margalit O, Mamtani R, Yang YX, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B.

Eur J Cancer. 2018 Jun;96:105-110. doi: 10.1016/j.ejca.2018.03.022. Epub 2018 Apr 24.

PMID:
29698932
6.

Assessing the prognostic value of carcinoembryonic antigen levels in stage I and II colon cancer.

Margalit O, Mamtani R, Yang YX, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B.

Eur J Cancer. 2018 May;94:1-5. doi: 10.1016/j.ejca.2018.01.112. Epub 2018 Mar 20.

PMID:
29502035
7.

Functional imaging of the interaction between gut microbiota and the human host: A proof-of-concept clinical study evaluating novel use for 18F-FDG PET-CT.

Boursi B, Werner TJ, Gholami S, Houshmand S, Mamtani R, Lewis JD, Wu GD, Alavi A, Yang YX.

PLoS One. 2018 Feb 15;13(2):e0192747. doi: 10.1371/journal.pone.0192747. eCollection 2018.

8.

Association Between Symptomatic Versus Asymptomatic Recurrence and Survival in Bladder Cancer.

Osterman CK, Alanzi J, Lewis JD, Kaufman EL, Narayan V, Boursi B, Vajravelu RK, Scott FI, Malkowicz SB, Mamtani R.

Clin Genitourin Cancer. 2018 Jun;16(3):235-239. doi: 10.1016/j.clgc.2017.11.001. Epub 2017 Dec 6.

PMID:
29287969
9.

Chronic therapy with selective serotonin reuptake inhibitors and survival in newly diagnosed cancer patients.

Boursi B, Lurie I, Haynes K, Mamtani R, Yang YX.

Eur J Cancer Care (Engl). 2018 Jan;27(1). doi: 10.1111/ecc.12666. Epub 2017 Mar 2.

PMID:
28252230
10.

Dr Lurie and Colleagues Reply. Antibiotics or Infection Itself? The Possible Importance of Inflammatory Cytokines on Mental States

Lurie I, Yang YX, Haynes K, Mamtani R, Boursi B.

J Clin Psychiatry. 2016 Dec;77(12):e1654. doi: 10.4088/JCP.16lr11074a. No abstract available.

11.

The Association between Age-Related Macular Degeneration and Renal Cell Carcinoma: A Nested Case-Control Study.

Keizman D, Yang YX, Gottfried M, Dresler H, Leibovitch I, Haynes K, Mamtani R, Boursi B.

Cancer Epidemiol Biomarkers Prev. 2017 May;26(5):743-747. doi: 10.1158/1055-9965.EPI-16-0759. Epub 2017 Jan 6.

12.

Proton pump inhibitors on pancreatic cancer risk and survival.

Kearns MD, Boursi B, Yang YX.

Cancer Epidemiol. 2017 Feb;46:80-84. doi: 10.1016/j.canep.2016.12.006. Epub 2017 Jan 2.

13.

A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes.

Boursi B, Finkelman B, Giantonio BJ, Haynes K, Rustgi AK, Rhim AD, Mamtani R, Yang YX.

Gastroenterology. 2017 Mar;152(4):840-850.e3. doi: 10.1053/j.gastro.2016.11.046. Epub 2016 Dec 5.

14.

Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710.

Ojerholm E, Smith A, Hwang WT, Baumann BC, Tucker KN, Lerner SP, Mamtani R, Boursi B, Christodouleas JP.

Cancer. 2017 Mar 1;123(5):794-801. doi: 10.1002/cncr.30422. Epub 2016 Oct 27.

15.

Pernicious anemia and colorectal cancer risk - A nested case-control study.

Boursi B, Mamtani R, Haynes K, Yang YX.

Dig Liver Dis. 2016 Nov;48(11):1386-1390. doi: 10.1016/j.dld.2016.07.011. Epub 2016 Jul 18.

PMID:
27481584
16.

Impact of metformin on the progression of MGUS to multiple myeloma.

Boursi B, Mamtani R, Yang YX, Weiss BM.

Leuk Lymphoma. 2017 May;58(5):1265-1267. doi: 10.1080/10428194.2016.1236375. Epub 2016 Oct 5. No abstract available.

17.

An association between newly diagnosed cutaneous T cell lymphoma and prior impetigo: a nested case-control study.

Boursi B, Haynes K, Mamtani R, Yang YX.

Arch Dermatol Res. 2016 Nov;308(9):661-664. Epub 2016 Sep 9.

PMID:
27613059
18.

Ion channel blockers and glioblastoma risk and outcome: a nested case-control and retrospective cohort studies.

Boursi B, Han HJ, Haynes K, Mamtani R, Yang YX.

Pharmacoepidemiol Drug Saf. 2016 Oct;25(10):1179-1185. doi: 10.1002/pds.4054. Epub 2016 Jul 7.

19.

Parkinson's disease and colorectal cancer risk-A nested case control study.

Boursi B, Mamtani R, Haynes K, Yang YX.

Cancer Epidemiol. 2016 Aug;43:9-14. doi: 10.1016/j.canep.2016.05.007. Epub 2016 May 24.

20.

Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study.

Mamtani R, Clark AS, Scott FI, Brensinger CM, Boursi B, Chen L, Xie F, Yun H, Osterman MT, Curtis JR, Lewis JD.

Arthritis Rheumatol. 2016 Oct;68(10):2403-11. doi: 10.1002/art.39738.

21.

Disentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control Study.

Mamtani R, Lewis JD, Scott FI, Ahmad T, Goldberg DS, Datta J, Yang YX, Boursi B.

PLoS Med. 2016 Apr 26;13(4):e1002007. doi: 10.1371/journal.pmed.1002007. eCollection 2016 Apr.

22.

Serum glucose and hemoglobin A1C levels at cancer diagnosis and disease outcome.

Boursi B, Giantonio BJ, Lewis JD, Haynes K, Mamtani R, Yang YX.

Eur J Cancer. 2016 May;59:90-98. doi: 10.1016/j.ejca.2016.02.018. Epub 2016 Mar 25.

23.

Reappraisal of risk factors for monoclonal gammopathy of undetermined significance.

Boursi B, Weiss BM, Haynes K, Mamtani R, Yang YX.

Am J Hematol. 2016 Jun;91(6):581-4. doi: 10.1002/ajh.24355. Epub 2016 Apr 13.

24.

A Risk Prediction Model for Sporadic CRC Based on Routine Lab Results.

Boursi B, Mamtani R, Hwang WT, Haynes K, Yang YX.

Dig Dis Sci. 2016 Jul;61(7):2076-86. doi: 10.1007/s10620-016-4081-x. Epub 2016 Feb 19.

PMID:
26894401
25.

Association of Itraconazole, a Hedgehog Inhibitor, and Bladder Cancer.

Mamtani R, Yang YX, Scott FI, Lewis JD, Boursi B.

J Urol. 2016 Aug;196(2):343-8. doi: 10.1016/j.juro.2016.01.089. Epub 2016 Jan 23.

26.

Antibiotic exposure and the risk for depression, anxiety, or psychosis: a nested case-control study.

Lurie I, Yang YX, Haynes K, Mamtani R, Boursi B.

J Clin Psychiatry. 2015 Nov;76(11):1522-8. doi: 10.4088/JCP.15m09961.

PMID:
26580313
27.

Applications of Fluorodeoxyglucose PET/Computed Tomography in the Assessment and Prediction of Radiation Therapy-related Complications.

Houshmand S, Boursi B, Salavati A, Simone CB 2nd, Alavi A.

PET Clin. 2015 Oct;10(4):555-71. doi: 10.1016/j.cpet.2015.05.003. Epub 2015 Jul 3. Review.

PMID:
26384600
28.

Recurrent antibiotic exposure may promote cancer formation--Another step in understanding the role of the human microbiota?

Boursi B, Mamtani R, Haynes K, Yang YX.

Eur J Cancer. 2015 Nov;51(17):2655-64. doi: 10.1016/j.ejca.2015.08.015. Epub 2015 Aug 31.

29.

Anti-depressant therapy and cancer risk: a nested case-control study.

Boursi B, Lurie I, Mamtani R, Haynes K, Yang YX.

Eur Neuropsychopharmacol. 2015 Aug;25(8):1147-57. doi: 10.1016/j.euroneuro.2015.04.010. Epub 2015 Apr 17.

PMID:
25934397
30.

Thyroid dysfunction, thyroid hormone replacement and colorectal cancer risk.

Boursi B, Haynes K, Mamtani R, Yang YX.

J Natl Cancer Inst. 2015 Apr 8;107(6):djv084. doi: 10.1093/jnci/djv084. Print 2015 Jun.

31.

Impact of antibiotic exposure on the risk of colorectal cancer.

Boursi B, Haynes K, Mamtani R, Yang YX.

Pharmacoepidemiol Drug Saf. 2015 May;24(5):534-42. doi: 10.1002/pds.3765. Epub 2015 Mar 23.

PMID:
25808540
32.

The effect of past antibiotic exposure on diabetes risk.

Boursi B, Mamtani R, Haynes K, Yang YX.

Eur J Endocrinol. 2015 Jun;172(6):639-48. doi: 10.1530/EJE-14-1163. Epub 2015 Mar 24.

33.

Validation of a coding algorithm to identify bladder cancer and distinguish stage in an electronic medical records database.

Mamtani R, Haynes K, Boursi B, Scott FI, Goldberg DS, Keefe SM, Vaughn DJ, Malkowicz SB, Lewis JD.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):303-7. doi: 10.1158/1055-9965.EPI-14-0677. Epub 2014 Nov 11.

34.

Height as an independent anthropomorphic risk factor for colorectal cancer.

Boursi B, Haynes K, Mamtani R, Yang YX.

Eur J Gastroenterol Hepatol. 2014 Dec;26(12):1422-7. doi: 10.1097/MEG.0000000000000209.

35.

Digoxin use and the risk for colorectal cancer.

Boursi B, Haynes K, Mamtani R, Yang YX.

Pharmacoepidemiol Drug Saf. 2014 Nov;23(11):1147-53. doi: 10.1002/pds.3717. Epub 2014 Sep 29.

36.

Experience with sunitinib treatment for metastatic renal cell carcinoma in a large cohort of Israeli patients: outcome and associated factors.

Livne-Segev D, Gottfried M, Maimon N, Peer A, Neumann A, Hayat H, Kovel S, Sella A, Mermershtain W, Rouvinov K, Boursi B, Weitzen R, Berger R, Keizman D.

Isr Med Assoc J. 2014 Jun;16(6):347-51.

37.

Active smoking may negatively affect response rate, progression-free survival, and overall survival of patients with metastatic renal cell carcinoma treated with sunitinib.

Keizman D, Gottfried M, Ish-Shalom M, Maimon N, Peer A, Neumann A, Hammers H, Eisenberger MA, Sinibaldi V, Pili R, Hayat H, Kovel S, Sella A, Boursi B, Weitzen R, Mermershtain W, Rouvinov K, Berger R, Carducci MA.

Oncologist. 2014 Jan;19(1):51-60. doi: 10.1634/theoncologist.2012-0335. Epub 2013 Dec 5.

38.

The APC p.I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews.

Boursi B, Sella T, Liberman E, Shapira S, David M, Kazanov D, Arber N, Kraus S.

Eur J Cancer. 2013 Nov;49(17):3680-5. doi: 10.1016/j.ejca.2013.06.040. Epub 2013 Jul 26.

PMID:
23896379
39.

One stop screening for multiple cancers: the experience of an integrated cancer prevention center.

Sella T, Boursi B, Gat-Charlap A, Aroch I, Liberman E, Moshkowitz M, Miller E, Gur E, Inbar R, Blachar A, Mabjeesh NJ, Rosenfeld O, Sperber F, Reiser V, Kleinman S, Jaffa AJ, Bloch M, Ormianer M, Naumov I, Kazanov D, Kraus S, Galazan L, Arber N.

Eur J Intern Med. 2013 Apr;24(3):245-9. doi: 10.1016/j.ejim.2012.12.012. Epub 2013 Jan 9.

PMID:
23312963
40.

Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma.

Keizman D, Ish-Shalom M, Pili R, Hammers H, Eisenberger MA, Sinibaldi V, Boursi B, Maimon N, Gottfried M, Hayat H, Peer A, Kovel S, Sella A, Berger R, Carducci MA.

Eur J Cancer. 2012 May;48(7):1031-7. doi: 10.1016/j.ejca.2012.02.050. Epub 2012 Mar 10.

PMID:
22409947
41.

Diagnostic and prognostic value of thrombocytosis in admitted medical patients.

Tchebiner JZ, Nutman A, Boursi B, Shlomai A, Sella T, Wasserman A, Guzner-Gur H.

Am J Med Sci. 2011 Nov;342(5):395-401. doi: 10.1097/MAJ.0b013e318214768d.

PMID:
21681080
42.

First report of screening an asymptomatic population for cancer: the yield of an integrated cancer prevention center.

Boursi B, Guzner-Gur H, Mashich Y, Miler U, Gur E, Inbar R, Blachar A, Sperber F, Kleiman S, Yafo A, Elran H, Sella T, Naumov I, Kazanov D, Kraus S, Galazan L, Reshef N, Sion-Tadmor T, Rozen M, Liberman E, Moshkowitz M, Arber N.

Isr Med Assoc J. 2010 Jan;12(1):21-5.

43.

Prognostic significance of serum uric acid in patients admitted to the Department of Medicine.

Wasserman A, Shnell M, Boursi B, Guzner-Gur H.

Am J Med Sci. 2010 Jan;339(1):15-21. doi: 10.1097/MAJ.0b013e3181bbb647.

PMID:
19996731
44.

Colonoscopic screening of an average-risk population for colorectal neoplasia.

Boursi B, Halak A, Umansky M, Galzan L, Guzner-Gur H, Arber N.

Endoscopy. 2009 Jun;41(6):516-21. doi: 10.1055/s-0029-1214757. Epub 2009 Jun 16.

PMID:
19533557
45.

Diagnostic and prognostic significance of serum C-reactive protein levels in patients admitted to the department of medicine.

Keshet R, Boursi B, Maoz R, Shnell M, Guzner-Gur H.

Am J Med Sci. 2009 Apr;337(4):248-55. doi: 10.1097/MAJ.0b013e31818af6de.

PMID:
19365169
46.
47.

[Small bowel malignancies: why are they so rare?].

Boursi B, Arber N.

Harefuah. 2004 Oct;143(10):727-32, 765. Review. Hebrew.

PMID:
15521350

Supplemental Content

Loading ...
Support Center